Resultados de la búsqueda 971-980 of 3169 for anti-TNF drugs
... treatment. A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline. Rochester, Minn ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...
https://www.arthritis.org/living-with-arthritis/treatments/medication/drug-types/corticosteroids/corticosteroid-injections.php. Accessed May 10, 2023. Joint ...
... Treatment Group (NCCTG). Este estudio está registrado en clinicaltrials.gov como NCT00005970. Para más información acerca de los tratamientos para el cáncer ...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU ... therapy. Numeración de páginas Estudios clínicos.
Cameron JL, et al., eds. Ablation of colorectal carcinoma liver metastases. In: Current Surgical Therapy. 14th ed. Elsevier; 2023. https://www.clinicalkey.com.
Thermal ablation for tumor treatment. American College of Radiology. https://www.radiologyinfo.org/en/info/thermal-ablation-therapy. Nov. 3, 2023 ...
Biological therapies in the treatment of cancer — Update and new directions. International Journal of Molecular Sciences. 2021; doi:10.3390/ijms222111694.
Doctors and researchers at Mayo Clinic are studying ways to improve treatment options for blood cancers, including CAR-T cell therapy and other innovations in ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?